Point72 Asset Management, L.P. - TERNS PHARMACEUTICALS INC ownership

TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 80 filers reported holding TERNS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of TERNS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,873,463
-61.4%
571,265
-9.2%
0.01%
-65.2%
Q1 2023$7,448,520
+213.4%
629,098
+169.4%
0.02%
+187.5%
Q4 2022$2,377,030
+91.7%
233,500
-53.3%
0.01%
+60.0%
Q2 2022$1,240,000
+240.7%
500,000
+307.9%
0.01%
+400.0%
Q1 2022$364,000122,5730.00%
Other shareholders
TERNS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 6,657,992$33,489,7003.67%
ACUTA CAPITAL PARTNERS, LLC 555,260$2,792,9581.87%
SUVRETTA CAPITAL MANAGEMENT, LLC 6,041,910$30,390,8071.64%
VR Adviser, LLC 3,092,273$15,554,1331.64%
Fairmount Funds Management LLC 2,040,000$10,261,2001.24%
Decheng Capital Management III (Cayman), LLC 714,285$3,592,8541.20%
Deep Track Capital, LP 6,000,000$30,180,0001.16%
Orbimed Advisors 7,619,135$38,324,2490.81%
SILVERARC CAPITAL MANAGEMENT, LLC 500,000$2,515,0000.76%
GREAT POINT PARTNERS LLC 645,899$3,248,8720.59%
View complete list of TERNS PHARMACEUTICALS INC shareholders